Inventor · disambiguated record
Masahiro Neya
Also filed as: NEYA MASAHIRO
22 granted patents·3 pending applications·313 citations·filing 1988–2021
95Inventor score
Files withFUJISAWA PHARMACEUTICAL CO14UNIV OSAKA3KNC LABORATORIES CO LTD2ASTELLAS PHARMA INC1KATAOKA TOHRU1
Top patents by PatentIndex Score
25 records- 0197US4963530ARenin inhibitor peptide compounds, a process for the preparation thereof and pharmaceutical composition comprising the sameFUJISAWA PHARMACEUTICAL CO·Filed 1988·Granted Oct 16, 1990·167 cites·10 claims
- 0274US6489324B2Piperazine compounds as inhibitors of MMP or TNFFUJISAWA PHARMACEUTICAL CO·Filed 2001·Granted Dec 3, 2002·6 cites·17 claims
- 0373US7872097B2Cyclic peptide compoundsASTELLAS PHARMA INC·Filed 2006·Granted Jan 18, 2011·2 cites·11 claims
- 0473US5430022APeptide compound and its preparationFUJISAWA PHARMACEUTICAL CO·Filed 1993·Granted Jul 4, 1995·29 cites·12 claims
- 0571US5284828APeptide compound and its preparationFUJISAWA PHARMACEUTICAL CO·Filed 1991·Granted Feb 8, 1994·33 cites·9 claims
- 0667US6967197B2Thiazepinyl hydroxamic acid derivatives as matrix metalloproteinase inhibitorsFUJISAWA PHARMACEUTICAL CO·Filed 2001·Granted Nov 22, 2005·5 cites·20 claims
- 0765US8802679B2Glycine compoundYOSHIHARA KOUSEI·Filed 2010·Granted Aug 12, 2014·2 cites·12 claims
- 0865US4921855ANew Histidyl amino acid derivatives, and pharmaceutical composition comprising the sameFUJISAWA PHARMACEUTICAL CO·Filed 1988·Granted May 1, 1990·10 cites·12 claims
- 0961US9056862B2Thioxothiazolidine derivative having Ras function inhibitory effectKATAOKA TOHRU·Filed 2012·Granted Jun 16, 2015·2 cites·25 claims
- 1058US5656604APeptide compound and its preparationFUJISAWA PHARMACEUTICAL CO·Filed 1995·Granted Aug 12, 1997·9 cites·12 claims
- 1157US6333324B1Piperazine compounds as inhibitors of MMP or TNFFUJISAWA PHARMACEUTICAL CO·Filed 1997·Granted Dec 25, 2001·11 cites·9 claims
- 1257US5491132AAmino acid derivatives, a process for the preparation thereof and pharmaceutical composition comprising the sameFUJISAWA PHARMACEUTICAL CO·Filed 1994·Granted Feb 13, 1996·11 cites·11 claims
- 1353US5142048AIntermediate for preparation of amino acid derivativesFUJISAWA PHARMACEUTICAL CO·Filed 1990·Granted Aug 25, 1992·8 cites·9 claims
- 1451US5223489AAmino acid derivatives, processes for the preparation thereof and pharmaceutical composition comprising the sameUJISAWA PHARMACEUTICAL CO LTD·Filed 1992·Granted Jun 29, 1993·5 cites·10 claims
- 1551US2003060473A1Piperazine compounds as inhibitors of MMP or TNFFUJISAWA PHARMACEUTICAL CO·Filed 2002·Application pending·0 cites
- 1649US2023272403A1Antisense oligonucleotide inducing exon skipping of angiotensin converting enzyme 2 geneKNC LABORATORIES CO LTD·Filed 2021·Application pending·0 cites
- 1748US11028390B2Antisense oligonucleotide controlling expression amount of TDP-43 and use thereofUNIV OSAKA·Filed 2018·Granted Jun 8, 2021·0 cites·16 claims
- 1846US5538950AEndothelin antagonists and their preparationFUJISAWA PHARMACEUTICAL CO·Filed 1992·Granted Jul 23, 1996·8 cites·24 claims
- 1945US10899790B2Method for modifying T cell populationUNIV OSAKA·Filed 2017·Granted Jan 26, 2021·0 cites·11 claims
- 2043US9771316B2Phenoxyalkylamine compoundUNIV OSAKA·Filed 2014·Granted Sep 26, 2017·0 cites·16 claims
- 2142US8252895B2Cyclic peptide compoundsNEYA MASAHIRO·Filed 2010·Granted Aug 28, 2012·0 cites·1 claims
- 2240US2004266826A1Thiophenylthiopyrane dioxides as mmp or tnf-alpha inhibitorsFiled 2002·Application pending·0 cites
- 2339US5888972APeptide compounds, their preparation and usesFUJISAWA PHARMACEUTICAL CO·Filed 1994·Granted Mar 30, 1999·4 cites·9 claims
- 2437US11891412B2Production of highly fat-soluble phosphoramiditeKNC LABORATORIES CO LTD·Filed 2018·Granted Feb 6, 2024·0 cites·6 claims
- 2534US6207686B1Endothelin antagonistsFUJISAWA PHARMACEUTICAL CO·Filed 1995·Granted Mar 27, 2001·1 cites·11 claims
Join the waitlist — get patent alerts
Get an alert when Masahiro Neya files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →